Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates.
Ontology highlight
SUBMITTER: Marc Hafner, Laura M. Heiser
PROVIDER: LDS-1362 | LINCS | 2017-02-01
REPOSITORIES: LINCS
ACCESS DATA